18 January 2021 | News
On January 21, 2021, representatives of the Company’s Management Board will take part in the Top Picks by Trigon conference. Celon Pharma was among 21 companies recommended by Trigon DM in 2021.
Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.
- Current report No. 7/2021 – The recommendation of the National Centre for Research and Development to co-fund a project for an inhaled drug candidate for the treatment of inflammatory and fibrotic lung diseases, including COVID-19 complicationsFebruary 10, 2021 Date: February 10, 2021, time: 5:42 PM Legal basis: Article 17 section 1 of the Market Abuse Regulation (MAR) - confidential information. Content of the report: ManagementRead more »
- Celon Pharma Announces Successful Completion of Phase 1A Trial of CPL’116, JAK-ROCK Inhibitor.Celon Pharma S.A. today announced the successful completion of its Phase 1A trial of its JAK/ROCK kinases dual inhibitor, CPL’116. CPL’116 was administered orally in single ascending doses in healthyRead more »
- Current report No. 6/2021 – Completion of a phase IA clinical trial of a drug based on an innovative JAK/ROCK inhibitor – CPL 409116February 9, 2021 Date: February 9, 2021, time: 8:56 AM Legal basis: Article 17 section 1 of the Market Abuse Regulation (MAR) – confidential information. In relation to the currentRead more »
Research and development
We create innovative drugs, that will change the lives of patients globally
We are leaders